AMD, AI and NVIDIA
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices Inc (NASDAQ:AMD) to enhance its AI drug discovery capabilities.
Strategists at HSBC led by Frank Lee lowered their price target on the shares to $110 from $200 and cut the rating to Reduce ...
AMD's progress in AI and server CPUs positions it to capture market share, with up to 70% upside potential based on my ...
Investing.com -- Shares of Absci Corporation (NASDAQ: ABSI) soared 50% following the announcement of a strategic ...
We recently compiled a list of the 10 Hottest Large-Cap Stocks Right Now. In this article, we are going to take a look at ...
Advanced Micro Devices' diversified revenue streams provide a cushion against potential slowdowns in AI hardware CapEx. See ...
So, Broadcom is likely to remain a top semiconductor stock going forward thanks to its sunny prospects in AI and a potential recovery in other markets. But is it worth buying this chipmaker over AMD ...
Chipmaker Nvidia shares surge after founder Jensen Huang unveils next generation of AI for gamers at CES 2025.
Nvidia stock fell Tuesday after Jensen Huang's CES keynote. Analysts share reasons why and look to what's ahead for the tech ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback